Ritter Pharmaceuticals Inc (RTTR): Knoll Capital Management Reports New Position

Page 7 of 7

Page 7 of 7 – SEC Filing
Cusip No. 767836109 13G Page 7 of 7 Pages
Item 8. Identification and Classification of Members of the
Group:

Not Applicable.

Item 9. Notice of Dissolution of Group:

 

Not Applicable

Item 10. Certifications:

By Signing below I certify that, to the
best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with
the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.

 

SIGNATURE

After reasonable inquiry
and to the best of its knowledge and belief, I certify (the undersigned certifies) that the information set forth in this statement
is true, complete and correct.

KNOLL CAPITAL MANAGEMENT, LP

By: /s/ Fred Knoll

Dated: October 5, 2016

Name: Fred Knoll

Title: President

/s/ Fred Knoll

Dated: October 5, 2016 Fred Knoll

 

GAKASA HOLDINGS, LLC

By: Knoll Capital Management, L.P.,

Investment Manager

By: /s/ Fred Knoll

Dated: October 5, 2016

Name: Fred Knoll

Title: President

Page 7 of 7

Follow Qualigen Therapeutics Inc. (NASDAQ:QLGN)

Page 7 of 7